Back to FDA Applications sponsored by VALEANT PHARMS INTL

FDA Drug Application 022205 by VALEANT PHARMS INTL

Application Number022205
Application Type New Drug Application
Sponsor ApplicantVALEANT PHARMS INTL
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP02/3/2012N31668000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022205s000lbl.pdf 2/6/2012
AP02/3/2012N31718000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022205s000ltr.pdf 2/8/2012
AP02/3/2012N36193000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022205_giazo_toc.cfm 6/4/2013
AP02/3/2012N36194000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022205Orig1s000SumR.pdf 6/4/2013
AP012/16/2013SLR38074001   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022205Orig1s001ltr.pdf 12/17/2013
AP012/16/2013SLR38256001   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022205Orig1s001lbl.pdf 1/13/2014
AP01/5/2015SCM       




Back to FDA Applications sponsored by VALEANT PHARMS INTL